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HISTORICAL NOTE
Orthosiphon stamineus (vernacular name: barbiflore, Java tea, misai kucing, kabling-gubat, kumis kucing, cat’s whiskers, 
kidney tea, rau meo, remujung, balbas pusa, moustaches de chat, and yaa nuat maeo; synonym: Clerodendranthus spicatus, 
Ocimum aristatum, Orthosiphon aristatus, Orthosiphon grandiflorus, Orthosiphon spicatus, Orthosiphonis folium) has 
long been used in traditional medicine in East India, Indo China, South East Asia, and tropical regions of Australia where 
the plant is usually found. O. stamineus belongs to the Lamiaceae family and is a perennial herb. The stem is four-angled 
reaching a height ranging from 0.3 to 1 m, and the flowers are white or pale lilac. The flower has stamens (>2 cm) 
extending from the corolla tube. The leaves are about 2–4 cm wide and 4–7 cm long and have a lanceolate-like, elliptical, 
or rhomboid shape. The aerial parts (dried stem and leaves) are commonly brewed as a tea for a variety of purposes, from 
treating inflammatory disorders to ailments of the urogenital tract. This plant is commonly used in South East Asian folk 
medicine for diabetes, hypertension, gallstone, tonsillitis, epilepsy, rheumatoid diseases, menstrual disorder, gonorrhoea, 
syphilis, renal calculus, lithiasis, edema, eruptive fever, influenza, hepatitis, and jaundice. However, scientific studies on 
the medicinal benefits of O. stamineus do not confirm all its traditional uses. Nevertheless, O. stamineus is well known for 
its potent diuretic effect, which is stronger than other natural diuretics (Burkill, 1966).
CHEMICAL COMPONENTS
Chemical compounds extracted from O. stamineus leaves vary greatly with the type of solvent used and the auxiliary 
energy the process is subjected to. Major compounds often found from O. stamineus extracts are rosmarinic acid, eupatorin, 
and sinensetin. In fact, these compounds are often used to standardize products derived from this plant. Extraction using 
water often produced a lower yield of flavonoids (i.e., sinensetin, eupatorin, eupatorin-5-methyl ether) due to the lower 
solubility of flavonoids in water (Pang et al., 2017). Extraction using pure organic solvents such as ethanol and isopropanol 
yielded the highest concentration of flavonoids (methoxylated compounds), but a very low concentration of rosmarinic acid 
(hydroxylated compounds). The presence of excessive energy during the extraction process may induce thermal degradation 
of polyphenolic compounds (Pang et al., 2014) and may produce danshenshu (Nuengchamnong et al., 2011) and caffeic 
acid. Extracts from O. stamineus were found to contain essential oil fragments, diterpenes, phenolic acid, and flavonoids. 
In addition, O. stamineus extract was found to be rich in potassium (Basheer and Majid, 2010). The full list of compounds 
found in O. stamineus is listed in Table 3.31.1.
TRADITIONAL USE
The diuretic effect of O. stamineus leaf extract has long been well known in the South East Asian community. Owing to 
such a benefit, decoctions of O. stamineus have been used in folk medicine for treatment of various kidney diseases from 
infection to renal calculi. Normally, urinary tract infection is treated with a decoction of fresh leaves taken twice a day, 
despite there being no systematic knowledge on the dosage required for effective treatment. A decoction of dried leaves 
is often used for treatment of strangury and dysuria. The whole plant either dried or fresh is used to treat kidney stones by 
traditional medical practitioners (Muhlisah, 2007). The Filipinos also take a decoction of the leaves to relieve gout (De 
Padua et al., 1987). The Kenyah people of Sarawak, Malaysia, use the young twigs and leaves of O. stamineus for treatment 
of backache (Chai, 2006).
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TABLE 3.31.1 Active Compounds From Orthosiphon stamineus
Type Compounds References
Phenolic acid Danshensu
Salvionolic acid B
Caftaric acid
Sagerinic acid
Nuengchamnong et al. (2011)
Rosmarinic acid
Caffeic acid
Lithospermic acid
Chicoric acid
Sumaryono et al. (1991)
Flavonoids Ladanein
Vomifoliol
7’,3’,4’-Tri-O-methylluteolin
6-Hydroxy-5,7,4’-trimethoxyflavone
Tezuka et al. (2000)
Eupatorin
Tetramethylscutellarein
5-Hydroxy-6,7,3’,4’-tetramethoxyflavone
3’-Hydroxy-5,6,7,4’-tetramethoxyflavone
Sinensetin
Pillion
Salvegenin
Cirsimaritin
Rhamnazin
Apigenin trimethyl ether
Luteolin tetramethyl ether
Malterud et al. (1989)
Essential oil fragments β-Caryophyllene
α-Humulene
β-Elemene
1-Octen-3-ol
β-Bourbonene
β-Pinene
Caryophyllene oxide
Camphene
Limonene
α-Pinene
1,8-Cineol
Borneol
Linalool
Camphor
Eugenol
p-Cymene
Carvone
Bornyl acetate
δ-Cadinene
Hossain et al. (2008)
Diterpenes Orthosiphols A–Z Awale et al. (2001, 2002, 2003), Masuda et al. (1992), 
Nguyen et al. (2004), Stampoulis et al. (1999), Takeda 
et al. (1993) and Tezuka et al. (2000)
 Staminols A–D Awale et al. (2003), Nguyen et al. (2004), Stampoulis 
et al. (1999) and Tezuka et al. (2000)
 Staminolactones A–B Stampoulis et al. (1999) and Tezuka et al. (2000)
 Secoorthosiphols A–C Awale et al. (2002) and Nguyen et al. (2004)
 Nororthosiphonolide A Awale et al. (2002)
 Norstaminolactone A Awale et al. (2002)
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MAIN ACTIONS
Antidiabetic Activity
Extracts from O. stamineus have antidiabetic properties which are believed to be due to their interaction with glucose 
metabolism (i.e., both inhibiting and increasing glucose uptake by diaphragm muscles). This plant is also reported as a 
popular antidiabetic alternative medicine for type II diabetes.
A chloroform subfraction of O. stamineus leaves containing eupatorin (1.48%) and sinensetin (2.26%) was found to 
inhibit glucose uptake in streptozotocin-induced diabetic rats at an intestinal absorption rate of 500–2000 μg/mL, although 
the effect is no better than the reference drug metformin (Mohamed et al., 2013). Mohamed et al. (2012) showed that a 50% 
ethanolic extract of O. stamineus leaves inhibits α-glucosidase (IC50 of 4.63 mg/mL) and α-amylase (IC50 of 36.70 mg/mL), 
which they attributed to the presence of sinensetin. Sinensetin had an IC50 of 0.66 g/mL and maximum inhibition of 89% 
(2.5 mg/mL) for α-glucosidase and an IC50 of 1.13 mg/mL and maximum inhibition of 85.8% (2.5 mg/mL) for α-amylase. 
Thus, the plant extract inhibits the process of converting carbohydrates to glucose and hence helps regulate glucose levels 
in diabetic patients. They stated that sinensetin outperformed the reference drug acarbose. Earlier, Sriplang et al. (2007) 
reported up to 35% reduction of blood glucose in streptozotocin-induced diabetic rats using 1000 mg/kg of O. stamineus 
water extract. They noted an effect comparable with that of the reference drug glibenclamide. Blood glucose reduction is 
not caused by sinensetin alone because the water extract usually has an almost undetectable amount of sinensetin (Pang 
et al., 2017). The fact that water extract is responsible for blood glucose reduction according to Sriplang et al. (2007) means 
water-soluble compounds other than sinensetin must be responsible for the same actions. Elucidation of these compounds 
still awaits further investigation.
Water extract does not stimulate insulin secretion when tested in vitro (Sriplang et al., 2007). Similarly, a chloroform 
subfraction of plant leaves containing eupatorin at 1.48% and sinensetin at 2.26% also fails to stimulate insulin secretion 
in diabetic rats at doses up to 1000 mg/kg for 2 weeks (Mohamed et al., 2013), although it was found to suppress insulin 
release in response to subcutaneous glucose load (Mohamed et al., 2011a) and oral glucose test (Sriplang et al., 2007).
O. stamineus extract has also been found to stimulate glycogen synthesis. Mohamed et  al. (2013) reported that 
chloroform extract containing 1.48% eupatorin and 2.26% sinensetin increased glucose uptake by diaphragm muscles at a 
rate of 2 mg/mL in a different way from that of insulin, despite not being effective at a lower concentration (i.e., 0.5–1 mg/
mL). It is possible that O. stamineus stimulates glucose uptake into muscle cells, even though it is not known whether this 
applies to the largest body of muscle (i.e., skeletal muscle).
Type Compounds References
 Norstaminols A–C Awale et al. (2002, 2003), Stampoulis et al. (1999) and 
Tezuka et al. (2000)
 Norstaminone A Awale et al. (2001)
 Neoorthosiphonone A Awale et al. (2004)
 Neoorthosiphols A–B Awale et al. (2001, 2003), Nguyen et al. (2004), Ohashi 
et al. (2000) and Shibuya et al. (1999)
 Siphonols A–E Awale et al. (2003)
 Orthochromene A Ohashi et al. (2000)
Triterpene Ursolic acid
Oleanolic acid
Betulinic acid
Tezuka et al. (2000)
Hydroxybetulinic acid
Maslinic acid
α-Amyrin
β-Amyrin
Hossain and Ismail (2013)
Benzochromene Methylripariochromene A Guerin et al. (1989)
TABLE 3.31.1 Active Compounds From Orthosiphon stamineus—cont’d
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Mohamed et  al. (2013) reported that a chloroform subfraction of plant leaves could reduce blood glucose level in 
 streptozotocin-induced diabetic rats. The dose ranged from 500 to 1000 mg/kg taken orally twice daily for 14 days. They 
noted potency was significantly less than the reference drug metformin at 500 mg/kg. O. stamineus water extract also yielded 
a 13% reduction in fasting blood glucose for a similar dose and duration (Sriplang et al., 2007). In terms of percentage 
reduction in fasting blood glucose a dose of 1000 mg/kg had a similar effect to that of the reference drug glibenclamide, but 
the glucose concentration of the latter was slightly lower. According to Mohamed et al. (2011b) the extract could reduce 
blood glucose in a subcutaneous glucose tolerance test without inducing hypoglycemia, which suggests that the mechanism 
of action is related to 5′-AMP-activated protein kinase (AMPK). O. stamineus plant extract has the potential to reduce 
blood glucose levels in diabetic subjects.
Diuretic Activity
O. stamineus water extract increased urine output in Sprague-Dawley rats and the diuretic activity was dose dependent (Adam 
et al., 2009). The diuretic effect was lower than those of furosemide and hydrochlorothiazide, the medicine often used for 
diuresis. They observed higher than normal urinary potassium excretion and elevated blood urea nitrogen, creatinine, and 
glucose levels, but all remained within the normal range. Methanol–water extract of O. stamineus leaves showed diuretic 
effects comparable with those of hydrochlorothiazide for both acute and chronic administration (Arafat et al., 2008). They 
reported a reduction in uric acid level after 6 h in much the same way as occurs with allopurinol for hyperuricemic rats.
The diuretic effect of O. stamineus extract is attributed to the presence of methoxy flavonoids (i.e., sinensetin and 
tetramethylscutellarein) which have an antagonistic effect on adenosine receptors (Yuliana et al., 2009). Thus, the diuretic 
properties of O. stamineus are due to the affinity of its active compounds to adenosine receptor ligands.
Nephroprotective Activity: Kidney Stone Treatment
Zhong et al. (2012) reported that O. stamineus extracts can reduce the synthesis of calcium-based stones in the kidneys. In 
their work calcium oxalate induced nephrolithiasis in rats fed with 80–160 mg/kg of O. stamineus extract. They used the 
phenolic, flavonoid, and polysaccharide content derived from the main O. stamineus extracts for the test. They observed that 
urinary calcium and oxalate excretion increased and that the effect was dose dependent. They concluded the polysaccharide 
extracts of O. stamineus provided the most significant reduction of CaOx crystal nucleation and aggregation. Rodgers 
et al. (2014) reported that O. stamineus water extract reduced the growth rate of calcium oxalate in much the same way as 
Cystone, although Cystone was more effective (30.9%) than O. stamineus water extract (20%) in reducing overall CaOx 
crystal size.
Premgamone et al. (2001) evaluated the effect of drinking O. stamineus tea made from 2.5 g of sun-dried plant material 
on 48 renal calculi subjects split into 2 groups for 18 months. They compared the effect with that of the reference drug (i.e., 
5–10 g granular sodium potassium citrate). They found a significant reduction in kidney stone size for both study groups at 
an annual rate of 28.6 ± 16.0% and 33.8 ± 23.6% for O. stamineus and sodium potassium citrate, respectively. At the end of 
treatment, 90% of initial clinical symptoms (i.e., back pain, headaches, and joint pain) were relieved. No side effects were 
reported from subjects with O. stamineus; however, fatigue and loss of appetite were observed in 26.3% of subjects treated 
with sodium potassium citrate. Currently, there is no evidence that the plant extract is more potent than the currently used 
drug. However, the plant has the potential to reduce calcium-based stones production in the kidneys with no side effects.
Antihypertensive Activity
A chloroform subfraction of O. stamineus extract containing methylripariochromene A was shown to reduce blood pressure 
in spontaneously hypertensive rats (Matsubara et al., 1999). Manshor et al. (2013) reported that 50% methanolic extract 
and water extract of O. stamineus at a dose of 1000 mg/kg can also reduce blood pressure in spontaneously hypertensive 
rats. It is not clear whether methylripariochromene A was present in the extract, since quantification of the compound was 
not reported. The greatest effect was found with the methanolic extract, but it was still less than that of the reference drug 
losartan.
In a random clinical study of 80 subjects, Cicero et al. (2012) reported a mild but notable reduction in systolic, diastolic, 
and pulse pressure in hypertensive dyslipidemic subjects treated with a nutraceutical containing O. stamineus for 8 weeks. 
They reported no significant difference in cardiovascular disease risk at the end of the trial. The antihypertensive effect of 
O. stamineus is notable, although less potent than that of the reference drug hydrochlorothiazide. Elsewhere, Trimarco et al. 
(2012) showed a significant reduction in mean 24-hour systolic and diastolic blood pressure levels compared with baseline 
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values for subjects treated with supplements containing O. stamineus from their clinical trial involving 27 subjects. In 
contrast, the subjects treated with a supplement containing a combination of policosanol, red yeast rice extract, berberine, 
folic acid, and coenzyme Q10 (without O. stamineus) showed no significant reduction in blood pressure. Earlier, Supari 
(2002) reported systolic and diastolic blood pressure equivalent to amlodipine in mild and moderate hypertensive subjects 
taking a mixture supplement of Apium graveolens and O. stamineus.
Hepatoprotective Activity
Yam et al. (2007) observed the hepatoprotective effect of O. stamineus 50% aqueous methanolic extracts on CCl4-induced 
rats. They monitored normalization of the liver rate function using alanine transaminase and aspartate transaminase as 
indicators. They found the effect was dose dependent and that it was only effective at higher doses (i.e., >250 mg/
kg). Alshawsh et  al. (2011) studied the hepatoprotective effect that a 95% ethanolic extract of O. stamineus given at 
rates of 100 and 200 mg/kg daily for 2  months had on thioacetamide-induced liver cirrhosis in rats. They found the 
hepatoprotective effect was dose dependent and that it was only significant at the higher dose (i.e., 200 mg/kg). They 
suggested the hepatoprotective effect was due to neutralization of the toxic compounds through the cytochrome p450 
pathway. Nevertheless, the hepatoprotective effect was less potent than the reference drug silymarin (50 mg/kg) which 
comes from milk thistle. All these studies show that O. stamineus extract possesses hepatoprotective properties, although 
clinical trials on humans are not available.
Gastroprotective Activity
Yam et al. (2009) studied the antiulcerogenic activity of O. stamineus methanolic extract using an ethanol-induced gastric 
ulcer rat model. They reported a marked histological improvement in the healing of mucosal damage in groups receiving O. 
stamineus methanolic extracts. They concluded the gastroprotective effects of O. stamineus extract were due to its ability 
to inhibit lipid peroxidation and stimulate gastric mucus secretion.
Antiproliferative Properties and Cancer Treatment
O. stamineus contains diterpenes and flavonoids that display mild antiproliferative properties against liver metastatic colon 
26-L5 carcinoma and human HT1080 fibrosarcoma cell lines (Awale et al., 2001, 2002). O. stamineus ethanolic extract 
was found to suppress HCT116 colorectal tumors in mice (Ahamed et al., 2012). The latter authors’ in vitro test shows that 
O. stamineus is noncytotoxic to colon cancer and endothelial cells, but it appears to suppress vascular endothelial growth 
factor. The anticancer properties of O. stamineus lack clinical evidence, and more studies are needed to further understand 
its efficacy.
TOXICITY
The LD50 of O. stamineus is estimated to be greater than 5000 mg/kg with no apparent toxicity reported in Sprague-
Dawley rats after 14 days. Despite a benign increase in liver weight and a reduction in serum enzymes (Chin et al., 2008) 
and despite the absence of toxicity at this dose being reproduced acutely (Abdullah et al., 2009) and subchronically over 
a period of 28 days with 50% ethanolic extract (Mohamed et al., 2011a), O. stamineus water extract showed no genotoxic 
effects in Salmonella and doses up to 4000 mg/kg showed no genotoxic effects in a mouse bone marrow test (Muhammad 
et al., 2011). O. stamineus extract is neither toxic nor genotoxic with tested doses five to ten times higher than effective 
supplemented doses.
ADVERSE EFFECTS AND INTERACTIONS WITH DRUGS
In most clinical studies, pregnant or lactating women, persons with liver or heart failure, and persons who have had a stroke 
are often excluded for safety reasons due to limited information available on interaction with O. stamineus. Caution should 
be observed in patients with hypertensive therapy when taking O. stamineus because there is a possibility of bringing about 
an orthostatic hypotensive attack (Globinmed, 2017). Garcia-Moran et al. (2004) wrote a letter to Gastroenterology and 
Hepatology complaining about potential development of acute hepatitis as a result of consuming O. stamineus tea; however, 
this claim has yet to be substantiated elsewhere. Moreover, O. stamineus is consumed widely as herbal tea in South East 
Asia without any reported complaint related to hepatitis.
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O. stamineus–based supplements should not be taken with other diuretics because such a combination may cause 
hypertension and congestive cardiac failure. In the presence of cardiac and renal insufficiency, caution is advised when 
taking this supplement. Adam et al. (2009) noted that there is a risk of hypoglycemia when O. stamineus is taken together 
with antidiabetic drugs.
CONCLUSIONS
It is clear from reviewing preclinical and clinical trials on O. stamineus that the plant shows significant promise as diuretic, 
antidiabetic, antihypertensive, nephroprotective, hepatoprotective, gastroprotective, antiproliferative and anticancer drug. 
The effective dose of the plant extract ranging from 200 to 1000 mg/kg is not toxic with the LD50 estimated to be greater 
than 5000 mg/kg. At present, how it interacta with other drugs is not yet fully understood. However, as a precaution it is 
recommended that O. stamineus–based supplements should not be taken in conjunction with other diuresis or hypertensive 
therapy.
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